venBio Select Advisor »

Incyte Corporation shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Incyte Corporation (INCY) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Incyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Incyte Corporation held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Incyte Corporation by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 135k 98.77
2017-12-31 $4.7M 50k 94.72

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Structure Therapeutics Sponsored Ads (GPCR)
Avidity Biosciences Common (RNA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Celcuity Common (CELC)
Apellis Pharmaceuticals Common (APLS)
Vera Therapeutics Common (VERA)
Spdr Series Trust - S&p Biotech Etf (XBI)
Xenon Pharmaceuticals Common (XENE)

View all positions for venBio Select Advisor

Top funds holding Incyte Corporation

Baker Bros. Advisors
Vanguard Group
BlackRock
Dodge & Cox
State Street Corporation
AQR Capital Management
Geode Capital Management
Renaissance Technologies
LSV Asset Management
Invesco
Arrowstreet Capital, Limited Partnership
Robeco Institutional Asset Management B V
Thomas Stevens, CFA"
Jacobs Levy Equity Management
Acadian Asset Management

View all funds holding Incyte Corporation